{"id":"https://openalex.org/W2140785273","doi":null,"title":"Topical retinoic acid reduces skin papilloma formation but resistant papillomas are at high risk for malignant conversion.","display_name":"Topical retinoic acid reduces skin papilloma formation but resistant papillomas are at high risk for malignant conversion.","publication_year":1998,"publication_date":"1998-04-01","ids":{"openalex":"https://openalex.org/W2140785273","mag":"2140785273","pmid":"https://pubmed.ncbi.nlm.nih.gov/9537245"},"language":"en","primary_location":{"id":"pmid:9537245","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9537245","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5050527834","display_name":"Tamar Tennenbaum","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I13955877","display_name":"Bar-Ilan University","ror":"https://ror.org/03kgsv495","country_code":"IL","type":"education","lineage":["https://openalex.org/I13955877"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"T Tennenbaum","raw_affiliation_strings":["Department of Life Sciences, Bar Ilan University, Ramat-Gan, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Life Sciences, Bar Ilan University, Ramat-Gan, Israel","institution_ids":["https://openalex.org/I13955877"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030776641","display_name":"David T. Lowry","orcid":"https://orcid.org/0000-0002-0235-3438","observed_orcids":["https://orcid.org/0000-0002-0235-3438"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D Lowry","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026395749","display_name":"Nadine Darwiche","orcid":"https://orcid.org/0000-0002-1862-5426","observed_orcids":["https://orcid.org/0000-0002-1862-5426"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N Darwiche","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004170368","display_name":"David L. Morgan","orcid":"https://orcid.org/0000-0002-4313-9729","observed_orcids":["https://orcid.org/0000-0002-4313-9729"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D L Morgan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071699188","display_name":"Marina Gartsbein","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Gartsbein","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090125940","display_name":"Laura A. Hansen","orcid":"https://orcid.org/0000-0003-3436-8412","observed_orcids":["https://orcid.org/0000-0003-3436-8412"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L Hansen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008550236","display_name":"Luigi M. De Luca","orcid":"https://orcid.org/0000-0002-2492-3075","observed_orcids":["https://orcid.org/0000-0002-2492-3075"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L M De Luca","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035360585","display_name":"Henry Hennings","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H Hennings","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5110222224","display_name":"S H Yuspa","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S H Yuspa","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.5815,"has_fulltext":false,"cited_by_count":23,"citation_normalized_percentile":{"value":0.59038479,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"58","issue":"7","first_page":"1435","last_page":"43"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.6044999957084656,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.6044999957084656,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11501","display_name":"TGF-\u03b2 signaling in diseases","score":0.10239999741315842,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11306","display_name":"Nonmelanoma Skin Cancer Studies","score":0.07750000059604645,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/topical-retinoic-acid","display_name":"topical retinoic acid","score":0.972000002861023},{"id":"https://openalex.org/keywords/skin-papilloma","display_name":"skin papilloma","score":0.9179999828338623},{"id":"https://openalex.org/keywords/malignant-transformation","display_name":"malignant transformation","score":0.9539999961853027},{"id":"https://openalex.org/keywords/phorbol-myristate-acetate","display_name":"phorbol myristate acetate","score":0.9409999847412109},{"id":"https://openalex.org/keywords/mezerein","display_name":"mezerein","score":0.9739999771118164},{"id":"https://openalex.org/keywords/sencar-mice","display_name":"SENCAR mice","score":0.8080000281333923},{"id":"https://openalex.org/keywords/keratinocyte-transformation","display_name":"keratinocyte transformation","score":0.8140000104904175},{"id":"https://openalex.org/keywords/alpha6beta4-integrin","display_name":"alpha6beta4 integrin","score":0.890999972820282},{"id":"https://openalex.org/keywords/retinoid-x-receptor-alpha","display_name":"retinoid X receptor alpha","score":0.9929999709129333},{"id":"https://openalex.org/keywords/tgf-beta1","display_name":"TGF-\u03b21","score":0.8259999752044678},{"id":"https://openalex.org/keywords/tgf-beta-signaling","display_name":"TGF-beta signaling","score":0.6930000185966492},{"id":"https://openalex.org/keywords/skin-carcinogenesis","display_name":"skin carcinogenesis","score":0.37400001287460327}],"concepts":[{"id":"https://openalex.org/C2776350393","wikidata":"https://www.wikidata.org/wiki/Q912796","display_name":"Papilloma","level":2,"score":0.7035309672355652},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6710717678070068},{"id":"https://openalex.org/C2781121885","wikidata":"https://www.wikidata.org/wiki/Q425517","display_name":"Retinoic acid","level":3,"score":0.5551787614822388},{"id":"https://openalex.org/C2779256057","wikidata":"https://www.wikidata.org/wiki/Q16909647","display_name":"Tumor progression","level":3,"score":0.5436917543411255},{"id":"https://openalex.org/C31033888","wikidata":"https://www.wikidata.org/wiki/Q752076","display_name":"Malignant transformation","level":2,"score":0.5112292766571045},{"id":"https://openalex.org/C2780122803","wikidata":"https://www.wikidata.org/wiki/Q7852681","display_name":"Tumor promotion","level":4,"score":0.49519529938697815},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.35356223583221436},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.35320335626602173},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.32853972911834717},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2993229627609253},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.22628936171531677},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.2012239694595337},{"id":"https://openalex.org/C555283112","wikidata":"https://www.wikidata.org/wiki/Q1637543","display_name":"Carcinogenesis","level":3,"score":0.1184971034526825},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000287","descriptor_name":"Administration, Topical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002273","descriptor_name":"Carcinogens","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002280","descriptor_name":"Basal Cell Carcinoma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002280","descriptor_name":"Basal Cell Carcinoma","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D002471","descriptor_name":"Cell Transformation, Neoplastic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004224","descriptor_name":"Diterpenes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007150","descriptor_name":"Immunohistochemistry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008807","descriptor_name":"Mice, Inbred BALB C","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010212","descriptor_name":"Papilloma","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D010641","descriptor_name":"Phenotype","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011230","descriptor_name":"Precancerous Conditions","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D013729","descriptor_name":"Terpenes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013755","descriptor_name":"Tetradecanoylphorbol Acetate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014157","descriptor_name":"Transcription Factors","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D014212","descriptor_name":"Tretinoin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014408","descriptor_name":"Biomarkers, Tumor","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D016212","descriptor_name":"Transforming Growth Factor beta","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D016588","descriptor_name":"Anticarcinogenic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018168","descriptor_name":"Receptors, Retinoic Acid","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018632","descriptor_name":"Mice, Inbred SENCAR","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047488","descriptor_name":"Retinoid X Receptors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"pmid:9537245","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9537245","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.333.6170","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.333.6170","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://cancerres.aacrjournals.org/content/58/7/1435.full.pdf","raw_type":"text"},{"id":"mag:2140785273","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9537245","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":38,"referenced_works":["https://openalex.org/W174749331","https://openalex.org/W221359381","https://openalex.org/W1542869389","https://openalex.org/W1563613529","https://openalex.org/W1588178578","https://openalex.org/W1594207405","https://openalex.org/W1607562326","https://openalex.org/W1721481112","https://openalex.org/W1981135369","https://openalex.org/W1984172347","https://openalex.org/W1988082111","https://openalex.org/W2022677479","https://openalex.org/W2026460094","https://openalex.org/W2035652631","https://openalex.org/W2058585600","https://openalex.org/W2059492449","https://openalex.org/W2067158924","https://openalex.org/W2074101255","https://openalex.org/W2083431364","https://openalex.org/W2084960544","https://openalex.org/W2088687188","https://openalex.org/W2091649522","https://openalex.org/W2092513068","https://openalex.org/W2101198453","https://openalex.org/W2114209008","https://openalex.org/W2115446435","https://openalex.org/W2118202420","https://openalex.org/W2120879030","https://openalex.org/W2128015147","https://openalex.org/W2146489952","https://openalex.org/W2147014342","https://openalex.org/W2149624798","https://openalex.org/W2154802841","https://openalex.org/W2157875627","https://openalex.org/W2163348570","https://openalex.org/W2166938992","https://openalex.org/W2171938297","https://openalex.org/W2319872820"],"related_works":["https://openalex.org/W2081833057","https://openalex.org/W2022677479","https://openalex.org/W2051806823","https://openalex.org/W2136373317","https://openalex.org/W1975856099","https://openalex.org/W2066720941","https://openalex.org/W1979173477","https://openalex.org/W7097673625","https://openalex.org/W2048820480","https://openalex.org/W1981135369"],"abstract_inverted_index":{"Retinoic":[0],"acid":[1],"(RA)":[2],"was":[3,64,69],"topically":[4],"applied":[5,113],"to":[6,230,239],"the":[7,13,42,52,76,94,115,130,151,155,160,197,201],"skin":[8],"of":[9,16,44,54,73,78,96,117,121,129,145,157,176,185,200,207],"Sencar":[10],"mice":[11],"during":[12,61,114,139],"promotion":[14],"phase":[15],"specific":[17],"tumor":[18,122,202],"induction":[19],"protocols":[20],"that":[21,59,83,102,107,136],"produce":[22],"papillomas":[23,45,58,79,137,228],"at":[24,124,241],"low":[25],"(12-O-tetradecanoylphorbol-13-acetate":[26],"promoted,":[27],"TPA)":[28],"or":[29],"high":[30,146],"(mezerein-promoted)":[31],"risk":[32],"for":[33,187],"premalignant":[34,118,177],"progression":[35,147],"and":[36,46,127,163,192,237],"malignant":[37,55,104],"conversion.":[38],"RA":[39,62,74,84,92,108,140,218,231],"consistently":[40],"reduced":[41],"yield":[43],"carcinomas":[47,240],"in":[48,57,99,133,150,196],"both":[49],"protocols,":[50],"but":[51,227],"frequency":[53],"conversion":[56,111],"emerged":[60],"treatment":[63,141],"not":[65,86],"reduced.":[66],"When":[67],"TPA":[68],"reapplied":[70],"after":[71],"cessation":[72],"treatment,":[75],"number":[77],"increased":[80,243],"2-fold,":[81],"suggesting":[82,106],"had":[85],"eliminated":[87],"initiated":[88],"cells.":[89],"In":[90,154],"vitro,":[91],"prevented":[93],"emergence":[95],"transformed":[97],"keratinocytes":[98],"an":[100,173,242],"assay":[101],"mimics":[103],"conversion,":[105],"can":[109,219],"suppress":[110],"if":[112],"stage":[116],"progression.":[119,178],"Examination":[120],"markers":[123],"weeks":[125],"14":[126],"22":[128],"tumor-induction":[131],"experiments":[132],"vivo":[134],"indicated":[135],"evolving":[138],"exhibited":[142],"a":[143,215,224],"phenotype":[144],"risk,":[148],"even":[149],"TPA-promoted":[152],"groups.":[153],"majority":[156],"these":[158,212],"tumors,":[159],"alpha6beta4":[161],"integrin":[162],"retinoid":[164],"X":[165],"receptor":[166],"alpha":[167],"transcripts":[168,186],"were":[169],"detected":[170],"suprabasally,":[171],"indicating":[172],"advanced":[174],"state":[175],"RA-treated":[179],"tumors":[180],"also":[181],"expressed":[182],"higher":[183],"levels":[184],"transforming":[188],"growth":[189],"factor":[190],"(TGF)-beta1":[191],"localized":[193],"TGF-beta1":[194,208],"peptide":[195],"basal":[198],"portions":[199],"fronds.":[203],"Because":[204],"up-regulated":[205],"expression":[206],"suppresses":[209],"papilloma":[210,221],"formation,":[211],"studies":[213],"suggest":[214],"mechanism":[216],"whereby":[217],"prevent":[220],"eruption":[222],"via":[223],"TGF-beta":[225,235],"intermediate,":[226],"resistant":[229],"may":[232],"have":[233],"altered":[234],"signaling":[236],"progress":[238],"frequency.":[244]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}